|
|
|
| Home » Ormeloxifene (Centchroman) |
|
Ormeloxifene (Centchroman) |
|
|
Ormeloxifene (Centchroman) is one of the common methods of birth control. It is one of the widely used selective oestrogen receptor modulator (SERM). Ormeloxifene (Centchroman) is used for causing asynchronous ovulation with the development of the lining of the uterus that prevents the implantation of the zygotes. Extensively used and obtainable as a method for birth control in India almost over the last two decades, this type of birth control method of Ormeloxifene (Centchroman) is marketed here as Saheli and in fact Ormeloxifene is available lawfully in India only.
The selective estrogen receptor modulators (SERMs) are one of the categories of medication which targets the estrogen receptor.
|
|
Ormeloxifene or Centchroman is popular widely as a non-steroidal or a non-hormonal contraceptive pill that is to be taken once in a week. Other than being marketed in India as Saheli, Ormeloxifene (Centchroman) has also been licensed with the trade names of Sevista and Centron. It acts as an estrogen in few parts of the body while in some other parts it acts as anti-estrogene. Ormeloxifene causes desynchronization in the menstrual cycle between the time period from ovulation to the creation of the lining of the uterus. When it was tried clinically, ovulation took place later in few females than the normal but in a many females it did not have an effect on ovulation and delayed the growth of the uterine lining. Ormeloxifene (Centchroman) actually accelerates the transfer of the eggs that have been fertilized along the fallopian tubule. The environment that it creates makes implantation impossible even if fertilization takes place.
Ormeloxifene (Centchroman) can be used both for birth control and for treating dysfunctional bleeding of the uterus. For birth control Ormeloxifene can be taken once in a week. The method of using it benefits both its manufacturer and developer as, the typical birth control pills are meant to be taken almost every day at the same time. The pills that contain only progestine excluding Cerazette, do not stably slow down ovulation and being late for even just 3 hours may increase the possibility of pregnancy due to the short duration of these pills on the mucus of the cervix. The weekly schedule that is needed to be followed for using Ormeloxifene in birth control benefits those women who choose to opt for oral contraception and also find it hard to stick to a strict daily schedule. If you want to start taking it you have to take it twice every week for the initial twelve weeks and from the thirteenth week onward you can take one every week. This is suggested for the use of Ormeloxifene (Centchroman) for offering backup protection to you in its first month of use.
Torrent Pharmaceuticals was the first to manufacture Ormeloxifene (Centchroman) licensing it with the trade name of Centron which was discontinued and another license was received by Hindustan Latex Ltd which currently manufactures Saheli. Ormeloxifene with the trade name of Sevista is nowadays being manufactured by Torrent Pharmaceuticals for treating dysfunctional bleeding of uterus.
You have got a comprehensible idea about the Ormeloxifene (Centchroman) from our site birthcontrolhub.com. If you are inquisitive enough to know more about the other types of Methods of Birth Control just click on the other links on our site birthcontrolhub.com.
|
|
|
|
|
